The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2022
Filed:
Jul. 19, 2018
Applicant:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;
Inventors:
Lingyun Wu, Shanghai, CN;
Xile Liu, Shanghai, CN;
Charles Z. Ding, Shanghai, CN;
Shuhui Chen, Shanghai, CN;
Lihong Hu, Shanghai, CN;
Lele Zhao, Shanghai, CN;
Wei Pan, Shanghai, CN;
Guoping Hu, Shanghai, CN;
Jian Li, Shanghai, CN;
Ning Zhao, Shanghai, CN;
Jun Zhao, Shanghai, CN;
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., Lianyungang, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 409/14 (2006.01); C07D 471/10 (2006.01); A61P 35/04 (2006.01); C07D 519/00 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07D 471/10 (2013.01); A61P 35/04 (2018.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 409/14 (2013.01); C07D 519/00 (2013.01); C07K 16/2863 (2013.01);
Abstract
Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.